This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Hyposplenism
D3_HYPOSPLENISM
splenic disease: A disease involving the spleen.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
49 |
4. Check minimum number of eventsNone |
49 |
5. Include endpointsNone |
49 |
6. Filter based on genotype QC (FinnGen only) |
49 |
Control definitions (FinnGen only)
- Control exclude
- D3_BLOODOTHER
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D73
- Name in latin
- Hyposplenismus
Similar endpoints
↥List of similar endpoints to
Hyposplenism
based on the number of shared cases.
Similar with more cases:
- Diseases of spleen
- Other diseases of blood and blood-forming organs, wide
- Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 277 | 148 | 127 |
| Only index persons | 251 | 138 | 113 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.00 | 0.00 | 0.00 |
| Only index persons | 0.00 | 0.01 | 0.00 |
| Median age at first event (years) | |||
| Whole population | 52.16 | 52.98 | 51.62 |
| Only index persons | 52.71 | 52.98 | 52.39 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 49 | 30 | 19 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 61.70 | 58.89 | 66.14 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
No data
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
20
11
30.03
26.16
2.8
1.4
%
94.8
90.3
0.18
20
11
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
18
10
27.87
23.24
2.9
1.6
g/l
3.3
4.2
—
18
10
(3036489) Thrombin time
19
14
21.53
21.47
2.8
1.3
s
21.7
21.2
0.21
19
14
(40758558) Short blood count panel - Blood
37
99
12.18
16.08
24.2
6.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
20
30
10.57
13.95
12.6
11.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
20
31
10.21
13.56
16.3
3.9
e9/l
99.6
73.9
0.86
13
22
(42870588) Differential panel, method unspecified - Blood
40
130
12.24
13.41
19.9
4.7
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
33
103
7.75
11.43
4.7
2.7
e6/l
0.6
0.4
0.33
27
75
(3018095) Leukocytes [#/volume] in Urine
38
140
8.64
10.96
5.0
3.5
e6/l
657.7
53.6
0.45
27
91
(36304419) Bacteria [Presence] in Urine
32
104
6.99
10.39
4.7
2.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
18
35
7.55
9.76
1.8
1.4
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
23
59
6.46
9.46
4.4
2.4
e6/l
1.6
0.8
—
10
30
(3002582) Erythrocytes [#/volume] in Urine
33
118
6.50
9.42
4.7
3.0
e6/l
198.0
17.9
0.51
27
89
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
33
129
5.77
8.20
4.7
2.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
22
61
5.73
8.16
4.5
2.4
e6/l
2.3
0.6
—
10
32
(3012544) pH of Venous blood
17
37
6.50
8.14
11.4
5.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
27
91
5.38
7.96
2.4
1.9
mg/l
3.4
2.8
0.40
21
78
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
11
15
9.17
7.89
2.7
1.1
g/l
0.0
0.0
0.00
11
15
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
11
15
9.17
7.89
2.7
1.1
g/l
0.0
0.0
0.00
11
15
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
11
16
8.58
7.48
2.7
1.1
g/l
0.0
0.0
0.00
11
16
(3013650) Neutrophils [#/volume] in Blood by Automated count
42
227
6.93
7.24
36.5
9.2
e9/l
4.5
4.2
0.31
42
195
(3042936) Bacteria identified in Isolate by Culture
20
56
5.34
7.23
3.5
3.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
13
24
7.01
7.21
17.1
14.3
mmol/l
10.0
10.5
0.08
13
24
(4035726)
16
39
5.61
6.69
1.9
1.3
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
28
109
4.66
6.65
5.7
3.4
umol/l
289.4
8585.5
1.06
23
94
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
19
7.18
6.42
2.7
1.1
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
10
16
7.60
6.22
4.9
2.1
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
26
100
4.41
6.18
12.2
2.2
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
11
20
6.80
6.12
8.3
12.3
%
91.9
94.2
0.37
11
20
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
34
162
4.59
5.98
2.5
1.9
pmol/l
98.0
92.0
0.30
21
84
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
8
5
18.68
5.62
1.8
1.2
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
29
128
4.10
5.57
13.7
2.2
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
8
13.41
5.54
1.3
2.4
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
25
102
3.96
5.32
14.4
4.7
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
9
9
11.90
5.27
1.8
2.7
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
23
89
3.99
5.27
1.9
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
20
71
4.07
5.15
2.0
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
17
54
4.29
5.07
2.2
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
12
29
5.16
4.95
2.9
3.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
22
88
3.72
4.72
2.0
1.7
g/l
1.7
2.9
0.93
12
50
(3001122) Ferritin [Mass/volume] in Serum or Plasma
33
173
3.78
4.66
13.1
2.6
ug/l
352.7
87.9
0.85
33
155
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
10
22
5.45
4.53
10.4
4.8
mmol/l
24.3
25.0
—
10
22
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
34
186
3.70
4.41
13.5
4.5
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
12
32
4.64
4.39
9.9
3.0
kpa
5.3
5.0
0.10
12
32
(3019309) Folate [Moles/volume] in Red Blood Cells
19
72
3.68
4.37
1.8
1.5
nmol/l
659.9
1154.9
3.13
14
59
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
9
14
7.59
4.20
8.8
49.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
14
46
3.86
3.90
2.4
1.4
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
11
30
4.44
3.89
8.3
25.3
g/l
104.8
126.7
1.83
11
30
(3011397) Hemoglobin [Presence] in Urine by Test strip
19
77
3.40
3.89
2.2
3.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
6
5
13.39
3.87
1.0
1.0
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
6
5
13.39
3.87
1.2
1.0
%
102.2
112.8
—
6
5
(4306422)
6
5
13.39
3.87
1.0
1.2
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
17
6.22
3.71
1.3
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
6
6
11.15
3.60
1.0
1.0
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
14
50
3.52
3.43
2.4
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
7
9.54
3.36
1.5
1.0
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
9
21
5.00
3.17
2.6
1.7
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
6
8
8.34
3.15
1.2
1.0
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
6
8
8.34
3.15
1.2
1.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
8
8.34
3.15
6.3
13.4
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
5
5
10.92
3.04
2.0
1.4
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
5
5
10.92
3.04
1.0
1.0
%
94.8
102.6
—
5
5
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
9
7.40
2.96
1.7
1.2
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
9
7.40
2.96
10.5
5.2
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
5
6
9.09
2.81
1.2
1.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
6
9.09
2.81
1.6
1.8
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
6
9.09
2.81
1.0
1.0
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
5
6
9.09
2.81
1.0
1.5
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
6
10
6.65
2.78
1.8
1.5
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
6
11
6.04
2.62
1.0
1.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
7
7.78
2.61
2.0
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
28
168
2.56
2.59
3.6
2.0
—
—
—
0
0
(3002256) Pathology report gross observation
12
46
3.13
2.58
2.2
1.2
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
7
17
4.61
2.46
1.7
1.2
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
8
6.80
2.43
1.6
1.1
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
5
8
6.80
2.43
11.0
2.8
%
55.4
63.1
—
5
8
(3037467) Urinalysis macro (dipstick) panel - Urine
39
280
2.92
2.42
4.6
4.0
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
13
55
2.86
2.36
1.3
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
6
13
5.09
2.35
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
21
115
2.45
2.30
3.7
2.9
mg/l
88.1
108.8
0.09
14
74
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
5
9
6.04
2.27
2.0
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
5
9
6.04
2.27
2.0
1.4
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
11
44
2.93
2.19
8.4
17.9
mmol/l
-2.0
1.3
1.23
11
31
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
7
20
3.90
2.14
8.1
3.0
%
1.0
0.7
—
7
20
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
10
5.42
2.12
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
10
5.42
2.12
1.0
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
10
5.42
2.12
1.0
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
6
15
4.40
2.11
1.2
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
11
4.92
1.99
1.0
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
36
262
2.41
1.95
5.2
3.6
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
36
262
2.41
1.95
5.7
3.0
u/l
49.0
48.4
0.02
31
244
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
15
76
2.40
1.89
2.6
1.6
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
11
48
2.67
1.86
1.8
2.1
—
—
—
0
0
(3000492) Spirometry study
8
30
2.98
1.82
1.8
1.2
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
37
277
2.37
1.81
5.9
4.4
—
432.3
—
0
8
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
5
13
4.15
1.76
2.0
2.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
13
4.15
1.76
2.2
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
20
119
2.15
1.73
4.2
3.4
mg/mmol
23.2
16.6
0.16
13
77
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
7
25
3.09
1.72
2.4
1.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
6
20
3.27
1.63
9.3
3.0
%
0.9
1.3
—
6
20
(4010399)
9
40
2.53
1.50
1.3
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
10
47
2.42
1.45
1.8
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
0
40
0.00
1.40
0.0
2.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
5
17
3.15
1.39
1.4
1.2
—
—
—
0
0
(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum
5
19
2.81
1.24
1.0
1.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
8
39
2.25
1.22
1.5
1.7
—
—
—
0
0
(3015736) pH of Urine
22
151
1.83
1.19
2.1
3.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
8
140
0.49
1.04
3.1
2.7
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
7
36
2.10
1.02
4.4
2.9
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
16
106
1.76
0.94
1.6
1.4
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
18
124
1.71
0.93
3.7
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
13
82
1.80
0.89
1.5
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
10
58
1.91
0.87
1.1
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
43
383
2.00
0.85
5.3
4.5
mmol/l
5.8
5.9
0.19
38
349
(3019060) Gas panel - Arterial blood
0
26
0.00
0.81
0.0
21.8
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
0
27
0.00
0.80
0.0
1.6
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
17
122
1.60
0.73
1.3
2.1
u/l
111.0
181.9
0.61
17
113
(3013512) EKG study
6
100
0.54
0.72
6.2
4.2
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
0
19
0.00
0.62
0.0
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
7
45
1.65
0.52
1.3
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
43
397
1.68
0.48
53.8
13.6
mg/l
29.3
25.1
0.39
38
297
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
32
280
1.41
0.47
3.9
2.9
—
—
—
0
0
(4034850)
0
15
0.00
0.42
0.0
16.9
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
39
357
1.45
0.40
7.9
5.3
mmol/mol
39.5
39.5
0.00
33
337
(3022145) Colonoscopy Study observation
5
38
1.35
0.24
1.0
1.2
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
8
101
0.75
0.24
2.3
3.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
5
41
1.24
0.23
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
0
10
0.00
0.21
0.0
51.1
—
0.9
—
0
10
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
0
10
0.00
0.21
0.0
51.1
—
1.8
—
0
10
(3022217) INR in Platelet poor plasma by Coagulation assay
6
47
1.31
0.21
35.0
24.9
—
1.3
—
0
8
(3020891) Body temperature
0
13
0.00
0.21
0.0
5.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
6
53
1.15
0.09
1.7
1.6
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
8
90
0.87
0.07
8.0
5.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
12
131
0.89
0.06
1.9
3.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
5
50
1.00
0.00
1.2
2.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
0
7
0.00
0.00
0.0
3.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
0
9
0.00
0.00
0.0
8.7
—
29.9
—
0
9
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
0
5
0.00
0.00
0.0
5.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
6
58
1.04
0.00
1.5
2.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
12.8
—
0
5
(3039000) Anion gap in Blood
0
6
0.00
0.00
0.0
83.3
—
12.0
—
0
6
(3045424) Erythrocytes [Presence] in Urine
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
0
6
0.00
0.00
0.0
83.3
—
105.7
—
0
6
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint D3_HYPOSPLENISM and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have D3_HYPOSPLENISM.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: D3_HYPOSPLENISM – Hyposplenism
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data